Roche's Avastin fails in stomach cancer trial | Reuters

Links shared publicly online about this topic.

  • 1,361
    total visits

Roche's Avastin fails in stomach cancer trial | Reuters

reuters.com

ZURICH (Reuters) - Roche Holding's cancer drug Avastin missed its main target in a late-stage trial when used with chemotherapy to treat patients with advanced stomach cancer, the Swiss drugmaker said

View full resource at reuters.com

Tags: Stomach, Cancer, Cancer Medication, Chemotherapy, Colorectal Cancer Medication, Stomach Cancer, Drug, Avastin

  • Share

Most Recently Shared on February 23, 2010 at 9:49 am By:

HITpol HealthIT Policy

Roche's Avastin fails in stomach cancer trial: ZURICH (Reuters) - Roche Holding's cancer drug Avastin missed its m... http://bit.ly/bJOrFM

2 years ago...

UPDATE 3-AstraZeneca's Recentin fails trial, hurts shares | Reuters

reuters.com — “* Recentin fails vs Roche's Avastin in late stage study * Analysts say data as expected, Crestor verdict next hurdle * More late stage Recentin trial data due in coming months * AstraZeneca's sharesView full resource at reuters.com

  • View Related
  • Share

Most Recently Shared on March 8, 2010 at 8:44 am By:

JohnCFierce John Carroll Health Communicator

AZ's Recentin flunks a head-to-head trial with Avastin, the reigning cancer champ. http://bit.ly/b8WELc

2 years ago...

Avastin fails stomach-cancer trial - FiercePharma

fiercepharma.com — “Roche got a big disappointment today: The cancer drug Avastin failed a clinical trial in stomach cancer, one of the new indications the drugmaker had been aiming for. The company had predicted sales... Read more...View full resource at fiercepharma.com

  • View Related
  • Share

Most Recently Shared on February 23, 2010 at 3:46 pm By:

Advertisement